ATP-dependent RNA helicase DDX1 is an enzyme that in humans is encoded by the DDX1gene.
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein of unknown function. It shows high transcription levels in 2 retinoblastoma cell lines and in tissues of neuroectodermal origin.
Kitajima Y, Yatsuki H, Zhang R, et al. (1994). "A novel human homologue of a dead-box RNA helicase family". Biochem. Biophys. Res. Commun. 199 (2): 748–754. doi:10.1006/bbrc.1994.1292. PMID8135819.
Akiyama K, Akao Y, Yokoyama M, et al. (1999). "Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines". Biochem. Mol. Biol. Int. 47 (4): 563–8. doi:10.1080/15216549900201603. PMID10319407.
Golembowski S, Gellrich S, von Zimmermann M, et al. (2000). "Clonal evolution in a primary cutaneous follicle center B cell lymphoma revealed by single cell analysis in sequential biopsies". Immunobiology. 201 (5): 631–44. doi:10.1016/s0171-2985(00)80080-7. PMID10834319.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–1178. doi:10.1038/nature04209. PMID16189514.
Kaneko S, Ohira M, Nakamura Y, et al. (2007). "Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma". J. Cancer Res. Clin. Oncol. 133 (3): 185–192. doi:10.1007/s00432-006-0156-y. PMID17028906.
Tu LC, Yan X, Hood L, Lin B (2007). "Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells". Mol. Cell Proteomics. 6 (4): 575–588. doi:10.1074/mcp.M600249-MCP200. PMID17220478.